Astrazeneca Stock
-
AstraZeneca forecasts 2022 growth even as COVID revenue wanesWhile sales of COVID-19 products are expected to decline by a low-to-mid 20s percentage this year, Astrazeneca forecast overall revenues to rise by a high teens percentage.ConsumerFeb 10, 2022
-
AstraZeneca says COVID-19 antibody drug 83% effective over six monthsAstraZeneca's treatment is given in one go, as two sequential shots in the arm.HealthNov 18, 2021
-
-
Advertisement
-
AstraZeneca’s coronavirus vaccine produces strong immune response in older adultsThe data suggests that those aged over 70, who are at higher risk of serious illness and death from COVID-19, could build robust immunity.HealthNov 19, 2020
Trending
-
‘Exceptional’ mortgage rates spotted in Canada after U.S. Fed rate cut24,470 Read
-
NDP to join Bloc in backing Liberals against non-confidence vote17,672 Read
-
‘I couldn’t stop crying’: Memorial grows for 5-year-old boy killed in home13,234 Read
-
Some of Canada’s airports are getting CT scanners. Here’s why12,606 Read
-
Mohamed Al-Fayed, whose son died with Princess Diana, accused of multiple rapes10,795 Read
-
Retired Quebec teacher buys winning lottery ticket at last minute, wins $40M8,807 Read
-
Top Videos
-
Raw Video: Police charged with assault after arrest in south Edmonton84 Viewed
-
Rally in Toronto calls for government action, compensation on Grassy Narrows mercury poisoning63 Viewed
-
Business Matters: ‘Exceptional’ mortgage rates spotted in Canada after U.S. Fed rate cut19 Viewed
-
Kamloops Red Bridge destroyed by fire18 Viewed
-
Duelling protests held in Edmonton over sexual orientation, gender identity policies in schools16 Viewed
-
New Brunswick election: Higgs went to ‘very dark place’ with Liberal joke, opponent says15 Viewed
-